Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite

The World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of mortality following snakebite occurs outside the hospital setting, making the temporal gap between a bite and antivenom administration a major...

Full description

Saved in:
Bibliographic Details
Main Authors: Tommaso C. Bulfone, Stephen P. Samuel, Philip E. Bickler, Matthew R. Lewin
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2018/4320175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849405183605342208
author Tommaso C. Bulfone
Stephen P. Samuel
Philip E. Bickler
Matthew R. Lewin
author_facet Tommaso C. Bulfone
Stephen P. Samuel
Philip E. Bickler
Matthew R. Lewin
author_sort Tommaso C. Bulfone
collection DOAJ
description The World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of mortality following snakebite occurs outside the hospital setting, making the temporal gap between a bite and antivenom administration a major therapeutic challenge. Small molecule therapeutics (SMTs) have been proposed as potential prereferral treatments for snakebite to help address this gap. Herein, we discuss the characteristics, potential uses, and development of SMTs as potential treatments for snakebite envenomation. We focus on SMTs that are secretory phospholipase A2 (sPLA2) inhibitors with brief exploration of other potential drug targets on venom molecules.
format Article
id doaj-art-451091c4e43d4597abd79f4b20589d3c
institution Kabale University
issn 1687-9686
1687-9694
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-451091c4e43d4597abd79f4b20589d3c2025-08-20T03:36:44ZengWileyJournal of Tropical Medicine1687-96861687-96942018-01-01201810.1155/2018/43201754320175Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of SnakebiteTommaso C. Bulfone0Stephen P. Samuel1Philip E. Bickler2Matthew R. Lewin3California Academy of Sciences, San Francisco, 94118 CA, USACalifornia Academy of Sciences, San Francisco, 94118 CA, USAUniversity of California, San Francisco, 94118 CA, USACalifornia Academy of Sciences, San Francisco, 94118 CA, USAThe World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of mortality following snakebite occurs outside the hospital setting, making the temporal gap between a bite and antivenom administration a major therapeutic challenge. Small molecule therapeutics (SMTs) have been proposed as potential prereferral treatments for snakebite to help address this gap. Herein, we discuss the characteristics, potential uses, and development of SMTs as potential treatments for snakebite envenomation. We focus on SMTs that are secretory phospholipase A2 (sPLA2) inhibitors with brief exploration of other potential drug targets on venom molecules.http://dx.doi.org/10.1155/2018/4320175
spellingShingle Tommaso C. Bulfone
Stephen P. Samuel
Philip E. Bickler
Matthew R. Lewin
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
Journal of Tropical Medicine
title Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
title_full Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
title_fullStr Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
title_full_unstemmed Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
title_short Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
title_sort developing small molecule therapeutics for the initial and adjunctive treatment of snakebite
url http://dx.doi.org/10.1155/2018/4320175
work_keys_str_mv AT tommasocbulfone developingsmallmoleculetherapeuticsfortheinitialandadjunctivetreatmentofsnakebite
AT stephenpsamuel developingsmallmoleculetherapeuticsfortheinitialandadjunctivetreatmentofsnakebite
AT philipebickler developingsmallmoleculetherapeuticsfortheinitialandadjunctivetreatmentofsnakebite
AT matthewrlewin developingsmallmoleculetherapeuticsfortheinitialandadjunctivetreatmentofsnakebite